drugset / Trial / NCT01470053

Efficacy and Safety of Mometasone Furoate Plus Azelastine HCl Combination Versus Mometasone Furoate Alone or Azelastine Alone in Patients With Perennial Allergic Rhinitis

NCT01470053

Phase 3 Completed 347 enrolled Hanlim Pharm. Co., Ltd.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate of efficacy and safety of mometasone furoate plus azelastine HCl in patients with perennial allergic rhinitis.

Timeline

Start
2011-03
Primary completion
2011-12
Completion
2012-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azelastine Small molecule Intranasal
Comparator Mometasone furoate Other / unclassified Intranasal